Announces Funding Round
Jack Kaye, Westhouse Chairman said "this funding round will allow Westhouse to complete on a number of targeted acquisitions and ensure that the company can continue to develop and support its technology to enable it to bring products to market in a timely manner"
Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.
Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.
About Westhouse Medical Services Plc
Westhouse Medical (FRA:5WM) consists of two wholly-owned subsidiaries: Westhouse Medical Ltd and Westhouse Medical Devices Ltd. Westhouse is expanding rapidly through the acquisition and expansion of primary healthcare businesses within Europe and North America". Westhouse Medical Services Plc has a dynamic range of Medical Services and Devices providing cutting edge innovation in the medical sectors such as a non-invasive
Test for Breast Cancer and a patented procedure to treat glaucoma. www.westhousemedical.com
Westhouse Medical Services Plc
Wedgewood Investment Group LLC.